Treatment of lupus crisis with IgIV

Intravenous Immunoglobulin (i.v.Ig) has been advocated as efficacious for Systemic Lupus Erytematosus (SLE) and Lupic Nephritis (LN) using high dosages, propitious a prolonged remission of SLE. We show the case of a male patient 16 years old, with SLE diagnosis until 1993, and LN phase IV. He attend...

Full description

Saved in:
Bibliographic Details
Published inRevista alergia Mexico (Tecamachalco, Pueblo, Mexico : 1993) Vol. 45; no. 6; pp. 143 - 146
Main Authors Vázquez García, M J, Olalde Carmona, R, Juárez, J A, Escárcega Barbosa, D
Format Journal Article
LanguageSpanish
Published Mexico 01.11.1998
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Intravenous Immunoglobulin (i.v.Ig) has been advocated as efficacious for Systemic Lupus Erytematosus (SLE) and Lupic Nephritis (LN) using high dosages, propitious a prolonged remission of SLE. We show the case of a male patient 16 years old, with SLE diagnosis until 1993, and LN phase IV. He attend to hospital with a Lupic Crisis, positives ANAs, DNAds, ScL 427, C3 45, C4 13, IgG 179, urinary sediment: leukocytes 30-40 xc, erythrocytes 8-10 xc. Renal failure: BUN 243, seric Cr: 10.16. I.v. Ig administrated 400 mgs k do. And nephrologic assistance, NK. There was improvement after infusion, clinical and serological, persisting with renal failure. The mechanism by which i.v. Ig might have effected improvement in this patient was reviewed. The use in our patient with SLE and LN was satisfactory. Is difficult affirm categorical the outcome or failure of i.v. Ig in patients with SLE, even report founded are only few cases report.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Report-3
ObjectType-Case Study-4
ISSN:0002-5151